ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;86:1982-1985. doi:10.1016/j.athoracsur.2008.04.092
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Reiner Koerfer
Aly El-Banayosy
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leontiadis, E.
Right arrow Articles by El-Banayosy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leontiadis, E.
Right arrow Articles by El-Banayosy, A.
Related Collections
Right arrow Mechanical Circulatory Assistance

Case Reports

Thoratec Left Ventricular Assist Device Removal After Toxic Myocarditis

Evangelos Leontiadis, MD, Michiel Morshuis, MD, Latif Arusoglu, MD, Dagmar Cobaugh, MD, Reiner Koerfer, MD, Aly El-Banayosy, MD*

Department of Thoracic and Cardiovascular Medicine, Heart and Diabetes Center North-Rhine Westphalia, Ruhr-University of Bochum, Bad Oeynhausen, Germany

Accepted for publication April 25, 2008.

* Address correspondence to Dr El-Banayosy, Heart and Diabetes Center North-Rhine Westphalia, Department of Thoracic and Cardiovascular Medicine, Georgstrasse 11, Bad Oeynhausen, D-32545, Germany (Email: abanayosy{at}hdz-nrw.de).

The clinical manifestation and natural history of myocarditis range is variable from asymptomatic stages to intractable circulatory compromise and death. Supportive therapy is paramount in the treatment of this condition. The use of mechanical circulatory support as bridge-to-recovery or bridge-to-transplantation in cases of cardiovascular collapse is often the only therapeutic option for these patients. We report the case of an adolescent boy with toxic myocarditis, due to cannabis abuse, who was supported with a Thoratec left ventricular assist device (Thoratec Laboratories Corp, Pleasanton, CA) for 96 days before device removal.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.